TGF-β2 and TGFBR3 were found upregulated in dormant basal type DTCs from breast cancer patient-derived xenograft (PDX) studies28, arguing that this pathway might regulate dormancy in multiple tissues and epithelial cancers. Here, TGFBR3 is linked to breast cancer.